Apolipoprotein(a) phenotypes predict the risk for carotid atherosclerosis in patients with end-stage renal disease.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Arteriosclerosis and Thrombosis A Journal of Vascular Biology

• Publication date

  1994-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.14.9.1405PMID 8068600
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [B-scan ultrasound findings in the carotid bifurcation area of hemodialysis patients].

  2008cited by this paper
• Genetics of the quantitative Lp(a) lipoprotein trait

  2004cited by this paper
• Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high density lipoprotein cholesterol and triglycerides.

  1994cited by this paper
• Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma concentrations after renal transplantation.

  1994cited by this paper
• The relation of lipoprotein[a] concentrations and apolipoprotein[a] phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study.

  1993cited by this paper
• Atherosclerotic changes in the femoral and carotid arteries in familial hypercholesterolemia. Ultrasonographic assessment of intima-media thickness and plaque occurrence.

  1993cited by this paper
• Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus.

  1993cited by this paper
• A prospective study of lipoprotein(a) and the risk of myocardial infarction.

  1993cited by this paper
• Lipoprotein (a) levels in end-stage renal failure and renal transplantation.

  1993cited by this paper
• Serum lipoprotein (a) levels in maintenance hemodialysis patients.

  1993cited by this paper
• Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).

  1993cited by this paper
• Lipoprotein(a) in patients with carotid atherosclerosis and ischemic cerebrovascular disorders.

  1993cited by this paper
• Lipoprotein (a) in patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis.

  1993cited by this paper
• Lipoprotein[a] as a risk factor for preclinical atherosclerosis.

  1993cited by this paper
• Relation of lipoprotein(a) to coronary heart disease and duplexsonographic findings of the carotid arteries in heterozygous familial hypercholesterolemia.

  1993cited by this paper
• Increased serum apolipoprotein(a) in patients with chronic renal failure treated with continuous ambulatory peritoneal dialysis.

  1992cited by this paper
• B-Scan-sonographische Befunde im Bereich der Karotisbifurkation von Hämodialysepatienten

  1992cited by this paper
• Predictive value of apolipoproteins in a prospective survey of coronary artery disease in men.

  1992cited by this paper
• Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

  1992cited by this paper
• Cardiovascular risk factors in chronic renal failure and hemodialysis populations.

  1992cited by this paper
• Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.

  1992cited by this paper
• Apo(a) isoforms predict risk for coronary heart disease. A study in six populations.

  1992cited by this paper
• Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).

  1992cited by this paper
• Plasma level of lipoprotein Lp(a) is high in predialysis or hemodialysis, but not in CAPD.

  1992cited by this paper
• Serum Lp(a) as a discriminant marker of early atherosclerotic plaque at three extracoronary sites in hypercholesterolemic men. The PCVMETRA Group.

  1992cited by this paper
• The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration

  1992cited by this paper
• Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes.

  1992cited by this paper
• Significant association between low-molecular-weight apolipoprotein(a) isoforms and intermittent claudication.

  1992cited by this paper
• Lipoprotein(a) Is an Independent Risk Factor for Cardiovascular Disease in Hemodialysis Patients

  1992cited by this paper
• High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.

  1992cited by this paper
• Lipid abnormalities in renal disease.

  1991cited by this paper
• Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.

  1991cited by this paper
• Ultrasonographically assessed carotid morphology and the risk of coronary heart disease.

  1991cited by this paper
• Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants.

  1991cited by this paper
• Expressed hypervariable polymorphism of apolipoprotein (a).

  1991cited by this paper
• Serum lipids and lipoproteins are less powerful predictors of extracranial carotid artery atherosclerosis than are cigarette smoking and hypertension.

  1991cited by this paper
• Noninvasive study of arterial hypertension and carotid atherosclerosis.

  1990cited by this paper
• Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect.

  1990cited by this paper
• Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

  1990cited by this paper
• Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study.

  1990cited by this paper
• Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.

  1990cited by this paper
• Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.

  1990cited by this paper
• Ultrasonic evaluation of early carotid atherosclerosis.

  1990cited by this paper
• The mysteries of lipoprotein(a).

  1989cited by this paper
• Lp(a) Phenotyping by Immunoblotting with Polyclonal and Monoclonal Antibodies

  1988cited by this paper
• Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

  1987cited by this paper
• Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.

  1987cited by this paper
• Risk factors for extracranial carotid artery atherosclerosis.

  1987cited by this paper
• Free and Apo B-associated Lpa-specific protein in human serum.

  1987cited by this paper
• Lipoprotein(a) as a strong indicator for cerebrovascular disease.

  1986cited by this paper
• The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels.

  1986cited by this paper
• A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis.

  1985cited by this paper
• Risk Factors and Raised Atherosclerotic Lesions in Coronary and Cerebral Arteries

  1981cited by this paper
• Lipoprotein Lp(a) and the risk for myocardial infarction.

  1981cited by this paper
• Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis.

  1979cited by this paper
• Accelerated atherosclerosis in prolonged maintenance hemodialysis.

  1974cited by this paper
• Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

  1972cited by this paper
• Lipid abnormalities in renal disease.

  1972cited by this paper
• CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography

  year unknowncited by this paper

• Rethinking cardiovascular risk: The emerging role of lipoprotein(a) screening

  2025cites this paper
• Lipoprotein(a) concentrations and cardiovascular disease in patients with chronic kidney disease: Results from the German Chronic Kidney Disease study

  2024cites this paper
• Lipoprotein(a), platelet function and cardiovascular disease

  2023cites this paper
• Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?

  2023cites this paper
• Lipoprotein(a) and kidney diseases

  2021cites this paper
• The Burden of Coronary Artery Disease in Chronic Kidney Disease

  2020cites this paper
• The role of lipoprotein (a) in chronic kidney disease

  2018cites this paper
• Beyond the traditional lipid parameters in chronic kidney disease.

  2017cites this paper
• Lipoprotein(a) in nephrological patients

  2017cites this paper
• Más allá de los parámetros lipídicos tradicionales en la enfermedad renal crónica

  2017cites this paper
• Correlation of Serum Magnesium with Lipid Profile in CKD Patients on Maintenance Hemodialysis

  2016cites this paper
• Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.

  2016cites this paper
• Association between serum magnesium levels with lipids profile in patients undergoing peritoneal dialysis and hemodialysis

  2015cites this paper
• New Insights into the Assembly and Metabolism of ApoB-Containing Lipoproteins from in vivo Kinetic Studies: Results on Healthy Subjects and Patients with Chronic Kidney Disease

  2012cites this paper
• Correlation of serum magnesium with dyslipidemia in patients on maintenance hemodialysis.

  2012cites this paper
• Pattern of lipid profile in patients on maintenance hemodialysis.

  2010cites this paper
• High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans.

  2008cites this paper
• Disease of the Month Lipoprotein Metabolism and Lipid Management in Chronic Kidney Disease

  2007cites this paper
• Atherosclerosis after kidney transplantation: changes of intima-media thickness of carotids during early posttransplant period.

  2007cites this paper
• Lipoprotein metabolism and lipid management in chronic kidney disease.

  2007cites this paper
• In vivo turnover study demonstrates diminished clearance of lipoprotein(a) in hemodialysis patients.

  2007cites this paper
• CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Kinetic Studies of Atherogenic Lipoproteins in Hemodialysis Patients: Do They Tell Us More about Their Pathology?

  2007cites this paper
• Atherosclerosis in hemodialysis patients: traditional and nontraditional risk factors.

  2006cites this paper
• Carotid plaques and their predictive value for cardiovascular disease and all-cause mortality in hemodialysis patients considering renal transplantation: a decade follow-up.

  2006cites this paper
• K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

  2005cites this paper
• Lipids and atherosclerosis

  2004cites this paper
• Epidemiology, pathophysiology and therapeutic implications of lipoprotein(a) in kidney disease

  2004cites this paper
• Cardiovascular disease and chronic kidney disease: insights and an update.

  2004cites this paper
• Manifestations and Risk Factors of Atherosclerosis in Chronic Renal Failure

  2004cites this paper
• Hyperhomocyst(e)inemia is an important risk factor for vascular disease in subjects with high-molecular weight apo(a) isoforms.

  2004cites this paper
• Reverse Epidemiologie bei nephrologischen Patienten: Paradoxe Risikofaktoren für Mortalität und Atherosklerose

  2004influential citation
• Risk factors for aortic atherosclerosis determined by transesophageal echocardiography in patients with CRF.

  2003cites this paper
• Atherosclerosis in Patients with End-Stage Renal Failure Prior to Initiation of Hemodialysis

  2003cites this paper
• Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.

  2003cites this paper
• Lipoprotein (a) levels in those with high molecular weight apo (a) isoforms may remain low in a significant proportion of patients with end-stage renal disease.

  2003cites this paper
• Cardiovascular Diseases and Hemodialysis: Novel Strategies for Diagnosis, Prevention and Treatment

  2003cites this paper
• Prevalence and progression of peripheral arterial calcifications in patients with ESRD.

  2003cites this paper
• THE CLINICAL EPIDEMIOLOGY OF CARDIOVASCULAR DISEASES IN CHRONIC KIDNEY DISEASE: Uremia‐Related Metabolic Cardiac Risk Factors in Chronic Kidney Disease

  2003cites this paper
• Serum Lipoprotein (a) Levels in Chronic Renal Failure and Liver Cirrhosis Patients. Relationship with Atherosclerosis

  2002cites this paper
• Race-specific association of lipoprotein(a) with vascular access interventions in hemodialysis patients: the CHOICE Study.

  2002cites this paper
• The Involvement of Pentosidine in Aortic Calcification Associated with Hemodialysis Patients

  2002cites this paper
• Post-methionine-load hyperhomocysteinemia and increased lipoprotein(a) are associated with renal metabolic dysfunction: a hypothesis.

  2002cites this paper
• Relation of Apo(a) Size to Carotid Atherosclerosis in an Elderly Multiethnic Population

  2002cites this paper
• Association of kidney function with serum lipoprotein(a) level: the third National Health and Nutrition Examination Survey (1991-1994).

  2002cites this paper
• Section VII. Vascular disease and risk factors.

  2002cites this paper
• Should lipoprotein(a) be measured in pediatric renal transplant recipients?

  2002cites this paper
• Cardiovascular Disease and Predisposing Factors in Chronic Renal Failure

  2001cites this paper
• Lipid changes and statins in chronic renal insufficiency and dialysis.

  2001cites this paper
• Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.

  2000cites this paper
• Hemodialysis Vascular Access Thrombosis and Lipoprotein(A)

  2000cites this paper
• [Association of lipoprotein(a) and apolipoprotein(a) phenotypes with coronary and carotid atherosclerosis in CHD men].

  2000cites this paper
• CAROTID ATHEROSCLEROSIS IN RENAL TRANSPLANT RECIPIENTS

  2000cites this paper
• An Increased Serum Level of Free Apo(a) in Renal Patients Is More Striking than that of Lp(a) and Is Influenced by Homocysteine

  2000cites this paper
• “Release” Intra- E Ost- Dialitico Di PDGF-AB

  2000cites this paper
• Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients.

  2000cites this paper
• The Significance of Atherogenic Indices in Patients on Hemodialysis

  2000cites this paper
• Stroke in Patients Undergoing Dialysis

  2000cites this paper
• Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.

  2000cites this paper
• Carotid atherosclerosis in renal transplant recipients.

  2000cites this paper
• Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.

  2000cites this paper
• Are lipid‐dependent indicators of cardiovascular risk affected by renal transplantation?

  2000cites this paper
• Should hyperlipidemia in children with the nephrotic syndrome be treated?

  1999cites this paper
• Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study.

  1999cites this paper
• [Genetic-epidemiological studies of apolipoprotein(a) polymorphism and its significance in nephrological diseases and type I diabetes mellitus].

  1999cites this paper
• Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).

  1999cites this paper
• The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up.

  1999cites this paper
• Genesis of Atherosclerosis in Uremic Patients

  1999cites this paper
• Is apolipoprotein(a) a susceptibility gene for Type I diabetes mellitus and related to long-term survival?

  1999cites this paper
• Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.

  1999cites this paper
• Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.

  1999cites this paper
• Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

  1999influential citation
• Carotid atherosclerosis in renal transplant recipients: relationships with cardiovascular risk factors and plasma lipoproteins.

  1999cites this paper
• PDGF-AB release during and after haemodialysis procedure.

  1999cites this paper
• Dyslipidaemia and cardiovascular risk in diabetes

  1999cites this paper
• Lipoprotein(a) plasma concentrations after renal transplantation: a prospective evaluation after 4 years of follow-up.

  1999cites this paper
• Genetics and metabolism of lipoprotein(a) and clinical implications (Part 2).

  1999cites this paper
• Lipoprotein(a): the really bad cholesterol?

  1999cites this paper
• Hyperlipidemia in patients with chronic renal disease.

  1998cites this paper
• Outcome of stroke in patients undergoing hemodialysis.

  1998cites this paper
• Lipid abnormalities in end stage renal disease.

  1998cites this paper
• Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.

  1998cites this paper
• Enhanced macrophage uptake of lipoprotein(a) after Ca2+-induced aggregate-formation

  1998cites this paper
• Mechanism for elevated plasma lipoprotein(a) concentrations in patients on dialysis: turnover studies.

  1998cites this paper
• Homocysteine, lipoprotein(a) and fibrinogen: metabolic risk factors for cardiovascular complications of chronic renal disease

  1998cites this paper
• Low Molecular Weight Heparin Reduces Triglyceride, VLDL and Cholesterol/HDL Levels in Hyperlipidemic Diabetic Patients on Hemodialysis

  1998cites this paper
• [Apolipoprotein (a) isoform size determination. Value and limits of high resolution phenotyping by agarose gel electrophoresis].

  1998cites this paper
• Insuffisance rénale chronique : étiologies, moyens de diagnostic précoce, prévention ?

  1998cites this paper
• Therapeutic efficiency of lipoprotein(a) reduction by low-density lipoprotein immunoapheresis.

  1998cites this paper
• Reassessing the cardiac risk profile in chronic hemodialysis patients: a hypothesis on the role of oxidant stress and other non-traditional cardiac risk factors.

  1997cites this paper
• Low‐density lipoprotein metabolism and its association to plasma lipoprotein(a) in the nephrotic syndrome

  1997cites this paper
• Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study.

  1997cites this paper
• Atypical presentation of stroke in a diabetic hemodialysis patient.

  1997cites this paper
• Lipoprotein(a): structural implications for pathophysiology

  1997cites this paper
• Increased plasma concentrations of LDL-unbound apo(a) in patients with end-stage renal disease.

  1997cites this paper
• Risk of fatal cerebrovascular accident in patients on peritoneal dialysis versus hemodialysis.

  1997cites this paper
• Lipoprotein(a) in nephrotic syndrome and end-stage renal disease.

  1997cites this paper
• Apolipoprotein B, fibrinogen, HDL cholesterol, and apolipoprotein(a) phenotypes predict coronary artery disease in hemodialysis patients.

  1997cites this paper
• Lipoprotein (a) and the kidney

  1997cites this paper
• Lipoprotein(a) in plasma, arterial wall, and thrombus from patients with aortic aneurysm

  1997cites this paper
• Atherosclerosis and arteriosclerosis in chronic renal failure.

  1997cites this paper